Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with Type 2 diabetes: A Go-DARTS study
SLCO1B1 gene variants are associated with severe statin-induced myopathy. We examined whether these variants are also associated with general statin intolerance in a large population of patients with type 2 diabetes receiving statins as part of routine clinical care. A total of 4,196 individuals wer...
Egile Nagusiak: | Donnelly, L, Doney, A, Tavendale, R, Lang, C, Pearson, E, Colhoun, H, McCarthy, M, Hattersley, A, Morris, A, Palmer, C |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
2011
|
Antzeko izenburuak
-
Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with type 2 diabetes: a go-DARTS study.
nork: Donnelly, L, et al.
Argitaratua: (2011) -
Effect of SLCO1B1 genotypes on statin intolerance and response
nork: R. Ghelani, et al.
Argitaratua: (2022-10-01) -
Loss-of-function CYP2C9 variants improve therapeutic response to sulfonylureas in type 2 diabetes: a Go-DARTS study.
nork: Zhou, K, et al.
Argitaratua: (2010) -
Reduced-function SLC22A1 polymorphisms encoding organic cation transporter 1 and glycemic response to metformin: a GoDARTS study.
nork: Zhou, K, et al.
Argitaratua: (2009) -
Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study.
nork: Pearson, E, et al.
Argitaratua: (2007)